Several studies presented at DDW 2026 highlighted emerging approaches that could reshape GI care, from less invasive Barrett’s esophagus surveillance…
Browsing: Clinical Updates
A favorable HHS-OIG advisory opinion could accelerate interest in multi-cancer early detection (MCED) testing by allowing a company to provide…
Five-year data from the Phase 2 GALAXI 1 trial show that Tremfya delivered durable clinical and endoscopic remission in patients…
The CU Anschutz IBD Biobank has partnered with health-tech startup Network.Bio to expand its collection and analysis of gut tissue…
The obesity treatment landscape is rapidly evolving beyond GLP-1 drugs, with researchers exploring new therapies designed to prevent weight regain,…
Geneoscopy announced that CMS has granted Medicare coverage for ColoSense®, the first FDA-approved stool RNA test for colorectal cancer screening,…
Researchers at Wilmington, Del.-based ChristianaCare’s Helen F. Graham Cancer Center & Research Institute identified a developmental genetic pattern tied to…
Prior authorizations remain a major barrier to IBD care, with surveys showing that nearly all gastroenterologists view them as burdensome…
Personalized nutrition is emerging as a major trend in gastroenterology, using microbiome data, biomarkers, genetics, and AI to tailor dietary…
Mindray has expanded its Hepatus ultrasound platform, combining diagnostic ultrasound with elastography and AI-powered image acquisition to create a unified…